...
首页> 外文期刊>British Journal of Haematology >Thrombopoietic status of patients on haemodialysis
【24h】

Thrombopoietic status of patients on haemodialysis

机译:血液透析患者的血小板生成状况

获取原文
获取原文并翻译 | 示例
           

摘要

Thrombocytopenia is a potential dialysis-related treatment complication. Developments in bio-compatible dialyser membranes have decreased the occurrence of thrombocytopenia. We investigated whether thrombopoiesis is impaired in haemodialysis patients by measuring the thrombopoietin level and absolute immature platelet number (AIPN) in the blood of patients undergoing haemodialysis. Samples were collected from the dialysis tubing pre- and post- haemodialysis in a cohort of 45 well-characterized haemodialysis patients. Thrombopoietin levels and AIPN increased following haemodialysis, despite no change in platelet count. Observed increase in release of immature platelets from the bone marrow following haemodialysis indicates possible complement activation secondary to interaction between blood constituents and the dialysis membrane.
机译:血小板减少症是与透析相关的潜在治疗并发症。生物相容性透析膜的发展减少了血小板减少症的发生。我们通过测量接受血液透析的患者血液中的血小板生成素水平和绝对未成熟血小板数(AIPN),调查了血液透析患者中​​的血小板生成是否受损。在45名特征明确的血液透析患者中​​,从血液透析前后的透析管中收集样品。血液透析后血小板生成素水平和AIPN升高,尽管血小板计数无变化。血液透析后观察到的未成熟血小板从骨髓中释放的增加表明可能继发于血液成分与透析膜之间相互作用的补体激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号